Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma - Peñate, Y; Hernández-Machín, B; Pérez-Méndez, L I (Br J Dermatol, 2012)
et al.